日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Resource and Reimbursement Barriers to Comprehensive Cancer Care Delivery: An Analysis of Association of Community Cancer Centers Survey Data

资源和报销障碍阻碍了综合癌症治疗的开展：社区癌症中心协会调查数据的分析

期刊:Jco Oncology Practice
影响因子:4.6
doi:10.1200/OP.22.00417
Benson, Al Bowen 3rd; Boehmer, Leigh; Mi, Xinlei; Kocherginsky, Masha; Shivakumar, Latha; Trosman, Julia R; Weldon, Christine B; Tina Shih, Ya-Chen; Hahn, Elizabeth A; Kircher, Sheetal M
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

IGF-Binding Proteins, Adiponectin, and Survival in Metastatic Colorectal Cancer: Results From CALGB (Alliance)/SWOG 80405

IGF结合蛋白、脂联素与转移性结直肠癌患者的生存率：来自CALGB（联盟）/SWOG 80405的研究结果

期刊:JNCI Cancer Spectrum
影响因子:4.1
doi:10.1093/jncics/pkaa074
Guercio, Brendan J; Zhang, Sui; Ou, Fang-Shu; Venook, Alan P; Niedzwiecki, Donna; Lenz, Heinz-Josef; Innocenti, Federico; Pollak, Michael N; Nixon, Andrew B; Mullen, Brian C; O'Neil, Bert H; Shaw, James E; Polite, Blase N; Benson, Al Bowen 3rd; Atkins, James N; Goldberg, Richard M; Brown, Justin C; O'Reilly, Eileen M; Mayer, Robert J; Blanke, Charles D; Fuchs, Charles S; Meyerhardt, Jeffrey A
肿瘤
肠癌
肿瘤免疫
发表日期：2021
文献求助 收藏

Nab-Paclitaxel and Gemcitabine as First-line Treatment of Advanced or Metastatic Cholangiocarcinoma: A Phase 2 Clinical Trial

白蛋白结合型紫杉醇联合吉西他滨一线治疗晚期或转移性胆管癌：一项II期临床试验

期刊:Jama Oncology
影响因子:20.1
doi:10.1001/jamaoncol.2018.3277
Sahai, Vaibhav; Catalano, Paul J; Zalupski, Mark M; Lubner, Sam Joseph; Menge, Mark R; Nimeiri, Halla Sayed; Munshi, Hidayatullah G; Benson, Al Bowen 3rd; O'Dwyer, Peter J
肿瘤
胆管癌
肿瘤免疫
发表日期：2018
文献求助 收藏

Financial Concerns About Participation in Clinical Trials Among Patients With Cancer

癌症患者参与临床试验的经济顾虑

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.2015.63.2463
Wong, Yu-Ning; Schluchter, Mark D; Albrecht, Terrance L; Benson, Al Bowen 3rd; Buzaglo, Joanne; Collins, Michael; Flamm, Anne Lederman; Fleisher, Linda; Katz, Michael; Kinzy, Tyler G; Liu, Tasnuva M; Manne, Sharon; Margevicius, Seunghee; Miller, Dawn M; Miller, Suzanne M; Poole, David; Raivitch, Stephanie; Roach, Nancy; Ross, Eric; Meropol, Neal J
肿瘤
肿瘤免疫
发表日期：2016
文献求助 收藏

CALGB 80403 (Alliance)/E1206: A Randomized Phase II Study of Three Chemotherapy Regimens Plus Cetuximab in Metastatic Esophageal and Gastroesophageal Junction Cancers

CALGB 80403 (Alliance)/E1206：三种化疗方案联合西妥昔单抗治疗转移性食管癌和胃食管交界处癌的随机 II 期研究

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.2015.65.5092
Enzinger, Peter C; Burtness, Barbara Ann; Niedzwiecki, Donna; Ye, Xing; Douglas, Kathe; Ilson, David H; Villaflor, Victoria Meucci; Cohen, Steven J; Mayer, Robert J; Venook, Alan; Benson, Al Bowen 3rd; Goldberg, Richard M
食管癌
肿瘤
肿瘤免疫
发表日期：2016
文献求助 收藏

Randomized Trial of a Web-Based Intervention to Address Barriers to Clinical Trials

一项旨在消除临床试验障碍的基于网络的干预措施的随机试验

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.2015.63.2257
Meropol, Neal J; Wong, Yu-Ning; Albrecht, Terrance; Manne, Sharon; Miller, Suzanne M; Flamm, Anne Lederman; Benson, Al Bowen 3rd; Buzaglo, Joanne; Collins, Michael; Egleston, Brian; Fleisher, Linda; Katz, Michael; Kinzy, Tyler G; Liu, Tasnuva M; Margevicius, Seunghee; Miller, Dawn M; Poole, David; Roach, Nancy; Ross, Eric; Schluchter, Mark D
发表日期：2016
文献求助 收藏

Phase II Trial of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin, and Bevacizumab Followed by Surgery and Postoperative 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX), and Bevacizumab in Patients With Locally Advanced Rectal Cancer: 5-Year Clinical Outcomes ECOG-ACRIN Cancer Research Group E3204

局部晚期直肠癌患者术前放疗联合卡培他滨、奥沙利铂和贝伐单抗化疗，随后行手术，术后行5-氟尿嘧啶、亚叶酸钙、奥沙利铂（FOLFOX）和贝伐单抗化疗的II期临床试验：5年临床结果 ECOG-ACRIN癌症研究组 E3204

期刊:Oncologist
影响因子:4.2
doi:10.1634/theoncologist.2015-0106
Landry, Jerome C; Feng, Yang; Prabhu, Roshan S; Cohen, Steven J; Staley, Charles A; Whittington, Richard; Sigurdson, Elin Ruth; Nimeiri, Halla; Verma, Udit; Benson, Al Bowen
肿瘤
肠癌
肿瘤免疫
发表日期：2015
文献求助 收藏

Phase II trial of bortezomib plus doxorubicin in hepatocellular carcinoma (E6202): a trial of the Eastern Cooperative Oncology Group.

硼替佐米联合多柔比星治疗肝细胞癌的 II 期试验 (E6202)：东部肿瘤协作组的一项试验

期刊:Investigational New Drugs
影响因子:2.7
doi:10.1007/s10637-014-0111-8
Ciombor Kristen K, Feng Yang, Benson Al Bowen 3rd, Su Yingjun, Horton Linda, Short Sarah P, Kauh John Sae Wook, Staley Charles, Mulcahy Mary, Powell Mark, Amiri Katayoun I, Richmond Ann, Berlin Jordan
细胞生物学
肿瘤
肿瘤免疫
发表日期：2014
文献求助 收藏

Phase 2 study of preoperative radiation with concurrent capecitabine, oxaliplatin, and bevacizumab followed by surgery and postoperative 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX), and bevacizumab in patients with locally advanced rectal cancer: ECOG 3204

一项针对局部晚期直肠癌患者的II期研究，评估术前放疗联合卡培他滨、奥沙利铂和贝伐单抗治疗，随后进行手术，术后给予5-氟尿嘧啶、亚叶酸钙、奥沙利铂（FOLFOX）和贝伐单抗治疗的疗效：ECOG 3204

期刊:Cancer
影响因子:5.1
doi:10.1002/cncr.27890
Landry, Jerome C; Feng, Yang; Cohen, Steven J; Staley, Charles A 3rd; Whittington, Richard; Sigurdson, Elin Ruth; Nimeiri, Halla; Verma, Udit; Prabhu, Roshan S; Benson, Al Bowen
肿瘤
肠癌
肿瘤免疫
发表日期：2013
文献求助 收藏

Association between VEGF splice isoforms and progression-free survival in metastatic colorectal cancer patients treated with bevacizumab

VEGF剪接异构体与接受贝伐单抗治疗的转移性结直肠癌患者的无进展生存期之间的关联

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-12-2223
Bates, David O; Catalano, Paul J; Symonds, Kirsty E; Varey, Alex H R; Ramani, Pramila; O'Dwyer, Peter J; Giantonio, Bruce J; Meropol, Neal J; Benson, Al Bowen; Harper, Steven J
EGF
肿瘤
VEGF
肠癌
肿瘤免疫
发表日期：2012
文献求助 收藏